Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $13.8 Million - $18.9 Million
-33,516 Reduced 98.37%
557 $232,000
Q2 2022

Aug 12, 2022

SELL
$463.67 - $597.16 $146,983 - $189,299
-317 Reduced 0.92%
34,073 $16.9 Million
Q1 2022

May 13, 2022

SELL
$524.57 - $735.42 $5.82 Million - $8.16 Million
-11,100 Reduced 24.4%
34,390 $19.4 Million
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $20.1 Million - $22.6 Million
-28,400 Reduced 38.44%
45,490 $34.4 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $23.1 Million - $29 Million
35,120 Added 90.59%
73,890 $55.1 Million
Q2 2021

Aug 13, 2021

BUY
$576.64 - $649.04 $438,823 - $493,919
761 Added 2.0%
38,770 $25 Million
Q1 2021

May 14, 2021

BUY
$547.01 - $662.35 $19.4 Million - $23.5 Million
35,464 Added 1393.48%
38,009 $21.7 Million
Q4 2020

Feb 12, 2021

SELL
$510.68 - $643.45 $232,359 - $292,769
-455 Reduced 15.17%
2,545 $1.48 Million
Q3 2020

Nov 13, 2020

SELL
$454.43 - $535.6 $45,443 - $53,560
-100 Reduced 3.23%
3,000 $1.55 Million
Q2 2020

Aug 14, 2020

BUY
$334.87 - $493.06 $736,714 - $1.08 Million
2,200 Added 244.44%
3,100 $1.4 Million
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $288,009 - $368,163
900 New
900 $316,000
Q1 2019

May 14, 2019

SELL
$224.3 - $317.41 $1.57 Million - $2.22 Million
-7,000 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$220.1 - $309.0 $2.2 Million - $3.09 Million
-10,000 Reduced 58.82%
7,000 $1.63 Million
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $4.92 Million - $5.54 Million
17,000 New
17,000 $5.32 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.